HASBROUCK HEIGHTS, N.J., March 15, 2018 /PRNewswire/ -- A new technology will be a game-changer in fertility treatment
URA is the first and only IVF center in the state to adopt this remarkable new technology into its already state-of-the-art IVF laboratory. The physicians, lab specialists, nurses and staff at URA deliver care 365 days each year to increase patients' pregnancy success rates; the LifeAire purification system should produce dramatic and sustained improvement in IVF success rates. With LifeAire technology, combined with an approach of complete, patient-centered dedication, URA strives to constantly improve success for their patients suffering from infertility and reproductive disorders.
URA's Laboratory Director of Embryology, Dr. Jindal, discusses the impact of LifeAire: "I have personally seen the LifeAire system produce amazingly improved outcomes at another IVF lab in Florida where I act as a consultant. More embryos develop into successful blastocysts, which is the stage embryos need to reach to be able to implant successfully, which leads to more available good, quality embryos for transfer or for freezing for future use. These laboratory improvements lead directly to dramatically better pregnancy rates and more successful IVF cycles."
URA physicians are recognized as leading authorities in the field by being chosen as reviewers and editors for prestigious medical journals, including Fertility and Sterility, Human Reproduction, Obstetrics and Gynecology, the American Journal of Obstetrics and Gynecology, the Journal of Clinical Endocrinology and Metabolism and Topics in Obstetrics and Gynecology. They are also educators for two separate OB/GYN residency programs, and they direct the only REI Fellowship training program based in the state of New Jersey.
Media contact:Leonard SchwartzUniversity Reproductive Associates201-288-7543 http://www.uranj.com/
View original content:http://www.prnewswire.com/news-releases/university-reproductive-associates-becomes-first-ivf-center-in-nj-to-offer-lifeaire-purification-300614617.html
SOURCE University Reproductive Associates (URA)
Subscribe to our Free Newsletters!
Osteolysis refers to breaking down of bone tissue. Bone loss occurs due to resorption of bone by ...
Patisiran injection, recently approved by FDA to treat polyneuropathy, a disease that causes ...
Dysgraphia or disorder of written expression is a childhood learning disorder marked by poor ...View All